Clinical Trial Update: A Study to Diagnose Lung Cancer by Sputum Cytology (01-312) [Phase 3]

View source ↗

Summary

Phase 3 study assessing sputum cytology to diagnose lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED